Multiple Sclerosis - News
U.S. health regulators said on Monday they could not definitively link Novartis AG's multiple sclerosis pill Gilenya with...
People with multiple sclerosis have long said that smoking marijuana helps ease their painful muscle cramping. And a new...
U.S. drug regulators are warning people with multiple sclerosis to avoid an experimental treatment that props open internal...
The Connecticut Senate passed a bill on Saturday legalizing marijuana use for medical purposes with tight restrictions aimed...
Many people with multiple sclerosis take fish oil pills with the hope of keeping neurological symptoms from getting worse,...
European and U.S. regulators have backed the continued use of Novartis AG's multiple sclerosis pill Gilenya, one of the Swiss...
A patient taking Novartis's multiple sclerosis pill Gilenya developed a rare and often fatal viral disease, the Swiss drugmaker...
The European Medicines Agency advised doctors to continuously monitor patients for six hours after giving them a first dose...
U.S. health regulators said on Tuesday they received a report of a multiple sclerosis patient who died within 24 hours of...
A third late-stage trial of Novartis' multiple sclerosis drug Gilenya did not throw up any new safety issues with the pill,...
A new analysis of past studies concludes that there seems to be some link between multiple sclerosis and narrowed head and...
A scientist who won the Nobel prize for medicine on Monday for work on fighting cancer died of the disease himself just three...
Three scientists who unlocked secrets of the body's immune system, opening doors to new vaccines and cancer treatments, won...
Life has taken long-distance runner Patrick Finney down many paths, but few have been so rewarding as the one that led him...
Despite a commonly-held belief among many doctors who treat lupus patients, headaches -- particularly migraines -- are not...
Scientists have found 29 new genetic variants linked to multiple sclerosis (MS) and say the findings should help drugmakers...
A new study provides more evidence that multiple sclerosis (MS) is not caused by a blood vessel condition, as some research...
Novartis's multiple sclerosis pill Gilenya, one of its biggest new drug hopes, has been rejected by Britain's healthcare...
Drugs used in the hope of slowing multiple sclerosis progression may help some patients, but at a very high cost, according...
Drugs used in the hope of slowing multiple sclerosis progression may help some patients, but at a very high cost, according...
Some studies have suggested that breastfeeding might offer women with multiple sclerosis a way to prevent symptom flare-ups...
A judge has blocked parts of a Montana law that would have imposed tough new restrictions on state-sanctioned medical marijuana...
People who get shingles are more likely to also develop multiple sclerosis, according to a study in Taiwan. Researchers found...
Having a stressful home or work environment doesn't make a person more likely to develop multiple sclerosis, hints a large...
People who have spent more time in the sun and those with higher vitamin D levels may be less likely to develop multiple...
Elan and Biogen Idec have asked regulators for a green light to change the label on the multiple sclerosis drug Tysabri (natalizumab)...
Four more patients taking Biogen Idec's multiple sclerosis drug Tysabri have developed the serious brain infection known...
Roche Holding AG and Biogen Idec Inc reported data from a mid-stage trial of their experimental multiple sclerosis drug ocrelizumab...
Swiss drugmaker Novartis AG said the average annual cost of its oral multiple sclerosis drug Gilenya will be $48,000 in the...
Whole-body vibration is pitched as a solution to everything from low bone density in astronauts to a better golf swing for...
Copyright ©2012 Thomson Reuters.
Click For Restrictions